Orthofix Medical Inc.
About Orthofix Medical Inc.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $822.3M
- Net income
- -$92.2M
- Total assets
- $850.6M
- Market cap
- $415.9M
- Gross margin
- 68.8%
- Operating margin
- -9.9%
- Net margin
- -11.2%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $822.3M
- Cost of revenue
- $256.3M
- Gross profit
- $566.0M
- Operating expenses
- $647.4M
- Operating income
- -$81.4M
- Income tax
- $1.4M
- Net income
- -$92.2M
- EPS (basic)
- $-2.33
- EPS (diluted)
- $-2.33
Balance sheet
- Total assets
- $850.6M
- Current assets
- $416.8M
- Total liabilities
- $400.6M
- Current liabilities
- $170.5M
- Shareholders’ equity
- $450.0M
Cash flow
- Operating cash flow
- $33.3M
- Investing cash flow
- -$34.6M
- Financing cash flow
- -$786.0K
- Net cash flow
- -$2.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $415.9M
- EPS (diluted)
- $-2.33
- Shares outstanding
- 42.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 24, 1992
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $92.2M in FY2025.
- Revenue grew 77% from FY2021 to FY2025.
- Gross margin of 68.8%, net margin -11.2%.
- Trading 40% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Orthofix Medical Inc..
Write a review
News about Orthofix Medical Inc.
News & sentiment via Polygon.io
